Alehagen U - Search Results

1

Dietary Supplementation with Selenium and Coenzyme Q₁₀ Prevents Increase in Plasma D-Dimer While Lowering Cardiovascular Mortality in an Elderly Swedish Population.

Alehagen U, Aaseth J, Lindahl TL, Larsson A, Alexander J. Alehagen U, et al. Nutrients. 2021 Apr 17;13(4):1344. doi: 10.3390/nu13041344. Nutrients. 2021. PMID: 33920725 Free PMC article. Clinical Trial.

2

Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure.

Alehagen U, Dahlström U, Lindahl TL. Alehagen U, et al. Thromb Haemost. 2004 Dec;92(6):1250-8. doi: 10.1160/TH04-05-0278. Thromb Haemost. 2004. PMID: 15583730

3

Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care.

Alehagen U, Dahlström U, Lindahl TL. Alehagen U, et al. Eur J Heart Fail. 2009 Apr;11(4):354-60. doi: 10.1093/eurjhf/hfp024. Epub 2009 Feb 19. Eur J Heart Fail. 2009. PMID: 19228797 Free article.

4

Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure.

Alehagen U, Dahlström U, Lindahl TL. Alehagen U, et al. Blood Coagul Fibrinolysis. 2010 Jan;21(1):62-9. doi: 10.1097/MBC.0b013e328332aa2b. Blood Coagul Fibrinolysis. 2010. PMID: 20040856

5

Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Alehagen U, Johansson P, Björnstedt M, Rosén A, Dahlström U. Alehagen U, et al. Int J Cardiol. 2013 Sep 1;167(5):1860-6. doi: 10.1016/j.ijcard.2012.04.156. Epub 2012 May 23. Int J Cardiol. 2013. PMID: 22626835 Free article. Clinical Trial.

6

Selenium and coenzyme Q10 interrelationship in cardiovascular diseases--A clinician's point of view.

Alehagen U, Aaseth J. Alehagen U, et al. J Trace Elem Med Biol. 2015;31:157-62. doi: 10.1016/j.jtemb.2014.11.006. Epub 2014 Nov 27. J Trace Elem Med Biol. 2015. PMID: 25511910 Free article. Review.

7

Relatively high mortality risk in elderly Swedish subjects with low selenium status.

Alehagen U, Johansson P, Björnstedt M, Rosén A, Post C, Aaseth J. Alehagen U, et al. Eur J Clin Nutr. 2016 Jan;70(1):91-6. doi: 10.1038/ejcn.2015.92. Epub 2015 Jun 24. Eur J Clin Nutr. 2016. PMID: 26105108 Free PMC article.

8

Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial.

Alehagen U, Lindahl TL, Aaseth J, Svensson E, Johansson P. Alehagen U, et al. PLoS One. 2015 Sep 16;10(9):e0137680. doi: 10.1371/journal.pone.0137680. eCollection 2015. PLoS One. 2015. PMID: 26375288 Free PMC article. Clinical Trial.

9

Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens.

Alehagen U, Aaseth J, Johansson P. Alehagen U, et al. PLoS One. 2015 Dec 1;10(12):e0141641. doi: 10.1371/journal.pone.0141641. eCollection 2015. PLoS One. 2015. PMID: 26624886 Free PMC article. Clinical Trial.

10

Less increase of copeptin and MR-proADM due to intervention with selenium and coenzyme Q10 combined: Results from a 4-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Alehagen U, Aaseth J, Johansson P. Alehagen U, et al. Biofactors. 2015 Nov-Dec;41(6):443-52. doi: 10.1002/biof.1245. Epub 2015 Dec 10. Biofactors. 2015. PMID: 26662217 Free article. Clinical Trial.

11

Supplementation with Selenium and Coenzyme Q10 Reduces Cardiovascular Mortality in Elderly with Low Selenium Status. A Secondary Analysis of a Randomised Clinical Trial.

Alehagen U, Alexander J, Aaseth J. Alehagen U, et al. PLoS One. 2016 Jul 1;11(7):e0157541. doi: 10.1371/journal.pone.0157541. eCollection 2016. PLoS One. 2016. PMID: 27367855 Free PMC article. Clinical Trial.

12

Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U. Aaseth J, et al. Among authors: alehagen u. Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16. Biometals. 2016. PMID: 27530256 Free PMC article. Review.

13

Significant changes in circulating microRNA by dietary supplementation of selenium and coenzyme Q10 in healthy elderly males. A subgroup analysis of a prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Alehagen U, Johansson P, Aaseth J, Alexander J, Wågsäter D. Alehagen U, et al. PLoS One. 2017 Apr 27;12(4):e0174880. doi: 10.1371/journal.pone.0174880. eCollection 2017. PLoS One. 2017. PMID: 28448590 Free PMC article. Clinical Trial.

14

Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Alehagen U, Johansson P, Aaseth J, Alexander J, Brismar K. Alehagen U, et al. PLoS One. 2017 Jun 13;12(6):e0178614. doi: 10.1371/journal.pone.0178614. eCollection 2017. PLoS One. 2017. PMID: 28609475 Free PMC article. Clinical Trial.

15

Copeptin Release in Cardiac Surgery-A New Biomarker to Identify Risk Patients?

Holm J, Szabó Z, Alehagen U, Lindahl TL, Cederholm I. Holm J, et al. Among authors: alehagen u. J Cardiothorac Vasc Anesth. 2018 Feb;32(1):245-250. doi: 10.1053/j.jvca.2017.06.011. Epub 2017 Jun 7. J Cardiothorac Vasc Anesth. 2018. PMID: 29102258

16

Less fibrosis in elderly subjects supplemented with selenium and coenzyme Q10-A mechanism behind reduced cardiovascular mortality?

Alehagen U, Aaseth J, Alexander J, Svensson E, Johansson P, Larsson A. Alehagen U, et al. Biofactors. 2018 Mar;44(2):137-147. doi: 10.1002/biof.1404. Epub 2017 Dec 8. Biofactors. 2018. PMID: 29220105 Clinical Trial.

17

Still reduced cardiovascular mortality 12 years after supplementation with selenium and coenzyme Q10 for four years: A validation of previous 10-year follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly.

Alehagen U, Aaseth J, Alexander J, Johansson P. Alehagen U, et al. PLoS One. 2018 Apr 11;13(4):e0193120. doi: 10.1371/journal.pone.0193120. eCollection 2018. PLoS One. 2018. PMID: 29641571 Free PMC article. Clinical Trial.

18

Decrease in inflammatory biomarker concentration by intervention with selenium and coenzyme Q10: a subanalysis of osteopontin, osteoprotergerin, TNFr1, TNFr2 and TWEAK.

Alehagen U, Alexander J, Aaseth J, Larsson A. Alehagen U, et al. J Inflamm (Lond). 2019 Mar 18;16:5. doi: 10.1186/s12950-019-0210-6. eCollection 2019. J Inflamm (Lond). 2019. PMID: 30923464 Free PMC article.

19

Significant Changes in Metabolic Profiles after Intervention with Selenium and Coenzyme Q10 in an Elderly Population.

Alehagen U, Johansson P, Aaseth J, Alexander J, Surowiec I, Lundstedt-Enkel K, Lundstedt T. Alehagen U, et al. Biomolecules. 2019 Sep 30;9(10):553. doi: 10.3390/biom9100553. Biomolecules. 2019. PMID: 31575091 Free PMC article. Clinical Trial.

20

Significant decrease of von Willebrand factor and plasminogen activator inhibitor-1 by providing supplementation with selenium and coenzyme Q10 to an elderly population with a low selenium status.

Alehagen U, Alexander J, Aaseth J, Larsson A, Lindahl TL. Alehagen U, et al. Eur J Nutr. 2020 Dec;59(8):3581-3590. doi: 10.1007/s00394-020-02193-5. Epub 2020 Feb 20. Eur J Nutr. 2020. PMID: 32078064 Free PMC article.

21

Supplemental selenium and coenzyme Q10 reduce glycation along with cardiovascular mortality in an elderly population with low selenium status - A four-year, prospective, randomised, double-blind placebo-controlled trial.

Alehagen U, Aaseth J, Alexander J, Johansson P, Larsson A. Alehagen U, et al. J Trace Elem Med Biol. 2020 May 4;61:126541. doi: 10.1016/j.jtemb.2020.126541. Online ahead of print. J Trace Elem Med Biol. 2020. PMID: 32417634 Free article.

22

Selenium and Coenzyme Q10 Supplementation Improves Renal Function in Elderly Deficient in Selenium: Observational Results and Results from a Subgroup Analysis of a Prospective Randomised Double-Blind Placebo-Controlled Trial.

Alehagen U, Aaseth J, Alexander J, Brismar K, Larsson A. Alehagen U, et al. Nutrients. 2020 Dec 9;12(12):3780. doi: 10.3390/nu12123780. Nutrients. 2020. PMID: 33317156 Free PMC article. Clinical Trial.

23

Effect of selenium and Q10 on the cardiac biomarker NT-proBNP.

Johansson P, Dahlström Ö, Dahlström U, Alehagen U. Johansson P, et al. Among authors: alehagen u. Scand Cardiovasc J. 2013 Oct;47(5):281-8. doi: 10.3109/14017431.2013.820838. Epub 2013 Jul 30. Scand Cardiovasc J. 2013. PMID: 23895165 Clinical Trial.

24

Cholecystokinin in plasma predicts cardiovascular mortality in elderly females.

Goetze JP, Rehfeld JF, Alehagen U. Goetze JP, et al. Among authors: alehagen u. Int J Cardiol. 2016 Apr 15;209:37-41. doi: 10.1016/j.ijcard.2016.02.038. Epub 2016 Feb 3. Int J Cardiol. 2016. PMID: 26878472

25

PDGF-D gene polymorphism is associated with increased cardiovascular mortality in elderly men.

Alehagen U, Olsen RS, Länne T, Matussek A, Wågsäter D. Alehagen U, et al. BMC Med Genet. 2016 Sep 1;17(1):62. doi: 10.1186/s12881-016-0325-z. BMC Med Genet. 2016. PMID: 27585990 Free PMC article.

26

Genetic variance and plasma concentration of CD93 is associated with cardiovascular mortality: Results from a 6.7‑year follow‑up of a healthy community‑living elderly population.

Alehagen U, Shamoun L, Wågsäter D. Alehagen U, et al. Mol Med Rep. 2020 Dec;22(6):4629-4636. doi: 10.3892/mmr.2020.11555. Epub 2020 Oct 1. Mol Med Rep. 2020. PMID: 33173973 Free PMC article.

27

The risk of cardiovascular death in elderly patients with possible heart failure. Results from a 6-year follow-up of a Swedish primary care population.

Alehagen U, Lindstedt G, Levin LA, Dahlström U. Alehagen U, et al. Int J Cardiol. 2005 Apr 8;100(1):17-27. doi: 10.1016/j.ijcard.2004.03.031. Int J Cardiol. 2005. PMID: 15820281

28

Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure.

Johansson P, Dahlström U, Alehagen U. Johansson P, et al. Among authors: alehagen u. Scand Cardiovasc J. 2007 Oct;41(5):299-307. doi: 10.1080/14017430701534829. Scand Cardiovasc J. 2007. PMID: 17852786

29

Global perceived health and ten-year cardiovascular mortality in elderly primary care patients with possible heart failure.

Johansson P, Broström A, Dahlström U, Alehagen U. Johansson P, et al. Among authors: alehagen u. Eur J Heart Fail. 2008 Oct;10(10):1040-7. doi: 10.1016/j.ejheart.2008.07.003. Epub 2008 Aug 6. Eur J Heart Fail. 2008. PMID: 18693135 Free article.

30

Increased IGF1 levels in relation to heart failure and cardiovascular mortality in an elderly population: impact of ACE inhibitors.

Chisalita SI, Dahlström U, Arnqvist HJ, Alehagen U. Chisalita SI, et al. Among authors: alehagen u. Eur J Endocrinol. 2011 Dec;165(6):891-8. doi: 10.1530/EJE-11-0584. Epub 2011 Oct 5. Eur J Endocrinol. 2011. PMID: 21976623

31

Proinsulin and IGFBP-1 predicts mortality in an elderly population.

Chisalita SI, Dahlström U, Arnqvist HJ, Alehagen U. Chisalita SI, et al. Among authors: alehagen u. Int J Cardiol. 2014 Jun 15;174(2):260-7. doi: 10.1016/j.ijcard.2014.03.171. Epub 2014 Apr 3. Int J Cardiol. 2014. PMID: 24794551 Free article.

32

The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.

Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP; Q-SYMBIO Study Investigators. Mortensen SA, et al. Among authors: alehagen u. JACC Heart Fail. 2014 Dec;2(6):641-9. doi: 10.1016/j.jchf.2014.06.008. Epub 2014 Oct 1. JACC Heart Fail. 2014. PMID: 25282031 Free article. Clinical Trial.

33

Gender difference in adiponectin associated with cardiovascular mortality.

Alehagen U, Vorkapic E, Ljungberg L, Länne T, Wågsäter D. Alehagen U, et al. BMC Med Genet. 2015 Jun 12;16:37. doi: 10.1186/s12881-015-0187-9. BMC Med Genet. 2015. PMID: 26068642 Free PMC article.

34

Improved Health-Related Quality of Life, and More Days out of Hospital with Supplementation with Selenium and Coenzyme Q10 Combined. Results from a Double Blind, Placebo-Controlled Prospective Study.

Johansson P, Dahlström Ö, Dahlström U, Alehagen U. Johansson P, et al. Among authors: alehagen u. J Nutr Health Aging. 2015 Nov;19(9):870-7. doi: 10.1007/s12603-015-0509-9. J Nutr Health Aging. 2015. PMID: 26482687 Clinical Trial.

35

Sex-Specific Associations Between Self-reported Sleep Duration, Cardiovascular Disease, Hypertension, and Mortality in an Elderly Population.

Broström A, Wahlin A, Alehagen U, Ulander M, Johansson P. Broström A, et al. Among authors: alehagen u. J Cardiovasc Nurs. 2018 Sep/Oct;33(5):422-428. doi: 10.1097/JCN.0000000000000393. J Cardiovasc Nurs. 2018. PMID: 28060086

36

Gender difference and genetic variance in lipoprotein receptor-related protein 1 is associated with mortality.

Alehagen U, Wågsäter D. Alehagen U, et al. Biomed Rep. 2019 Jul;1(1):1-5. doi: 10.3892/br.2019.1217. Epub 2019 May 24. Biomed Rep. 2019. PMID: 31258899 Free PMC article.

37

Increased cardiovascular mortality in females with the a/a genotype of the SNPs rs1478604 and rs2228262 of thrombospondin-1.

Alehagen U, Shamoun L, Wågsäter D. Alehagen U, et al. BMC Med Genet. 2020 Sep 11;21(1):179. doi: 10.1186/s12881-020-01118-7. BMC Med Genet. 2020. PMID: 32917134 Free PMC article.

38

Increased mortality in the A/A genotype of the SNP rs28372698 of interleukin 32.

Alehagen U, Shamoun L, Dimberg JI, Wågsäter D. Alehagen U, et al. Exp Ther Med. 2021 Feb;21(2):127. doi: 10.3892/etm.2020.9559. Epub 2020 Dec 7. Exp Ther Med. 2021. PMID: 33376509 Free PMC article.

39

Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.

Alehagen U, Svensson E, Dahlström U. Alehagen U, et al. J Card Fail. 2007 Aug;13(6):452-61. doi: 10.1016/j.cardfail.2007.03.002. J Card Fail. 2007. PMID: 17675059

40

Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure.

Alehagen U, Dahlström U. Alehagen U, et al. Int J Cardiol. 2009 Apr 3;133(2):233-40. doi: 10.1016/j.ijcard.2007.12.109. Epub 2008 Apr 14. Int J Cardiol. 2009. PMID: 18407361

41

The association between circulating angiotensin-converting enzyme and cardiovascular risk in the elderly: a cross-sectional study.

Ljungberg L, Alehagen U, Länne T, Björck H, De Basso R, Dahlström U, Persson K. Ljungberg L, et al. Among authors: alehagen u. J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):281-9. doi: 10.1177/1470320310391326. Epub 2011 Jan 27. J Renin Angiotensin Aldosterone Syst. 2011. PMID: 21273224 Free article.

42

Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. JAMA. 2011 May 25;305(20):2088-95. doi: 10.1001/jama.2011.666. JAMA. 2011. PMID: 21610241

43

Sleep disordered breathing in community dwelling elderly: associations with cardiovascular disease, impaired systolic function, and mortality after a six-year follow-up.

Johansson P, Alehagen U, Ulander M, Svanborg E, Dahlström U, Broström A. Johansson P, et al. Among authors: alehagen u. Sleep Med. 2011 Sep;12(8):748-53. doi: 10.1016/j.sleep.2011.03.012. Epub 2011 Jul 2. Sleep Med. 2011. PMID: 21724460

44

Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure.

Goetze JP, Hilsted LM, Rehfeld JF, Alehagen U. Goetze JP, et al. Among authors: alehagen u. Endocr Connect. 2014 Mar 11;3(1):47-56. doi: 10.1530/EC-14-0017. Print 2014. Endocr Connect. 2014. PMID: 24532383 Free PMC article.

45

Association between use of statins and outcomes in heart failure with reduced ejection fraction: prospective propensity score matched cohort study of 21 864 patients in the Swedish Heart Failure Registry.

Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Alehagen U, et al. Circ Heart Fail. 2015 Mar;8(2):252-60. doi: 10.1161/CIRCHEARTFAILURE.114.001730. Epub 2015 Jan 9. Circ Heart Fail. 2015. PMID: 25575580

46

Sickness behavior in community-dwelling elderly: associations with impaired cardiac function and inflammation.

Johansson P, Riegel B, Svensson E, Broström A, Alehagen U, Dahlström U, Jaarsma T. Johansson P, et al. Among authors: alehagen u. Biol Res Nurs. 2014 Jan;16(1):105-13. doi: 10.1177/1099800412466170. Epub 2012 Nov 15. Biol Res Nurs. 2014. PMID: 23162010

47

Association Between Use of Statins and Mortality in Patients With Heart Failure and Ejection Fraction of ≥50.

Alehagen U, Benson L, Edner M, Dahlström U, Lund LH. Alehagen U, et al. Circ Heart Fail. 2015 Sep;8(5):862-70. doi: 10.1161/CIRCHEARTFAILURE.115.002143. Epub 2015 Aug 4. Circ Heart Fail. 2015. PMID: 26243795 Clinical Trial.

48

Circulating microRNA-29-5p can add to the discrimination between dilated cardiomyopathy and ischaemic heart disease.

Brundin M, Wågsäter D, Alehagen U, Carlhäll CJ. Brundin M, et al. Among authors: alehagen u. ESC Heart Fail. 2021 Oct;8(5):3865-3874. doi: 10.1002/ehf2.13458. Epub 2021 Jun 26. ESC Heart Fail. 2021. PMID: 34173728 Free PMC article.

49

Utility of the amino-terminal fragment of pro-brain natriuretic peptide in plasma for the evaluation of cardiac dysfunction in elderly patients in primary health care.

Alehagen U, Lindstedt G, Eriksson H, Dahlström U. Alehagen U, et al. Clin Chem. 2003 Aug;49(8):1337-46. doi: 10.1373/49.8.1337. Clin Chem. 2003. PMID: 12881450

50

Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population.

Alehagen U, Lindstedt G, Levin LA, Dahlström U. Alehagen U, et al. Int J Cardiol. 2005 Apr 8;100(1):125-33. doi: 10.1016/j.ijcard.2004.10.006. Int J Cardiol. 2005. PMID: 15820295

51

Serum prolactin and macroprolactin in heart failure: no relation to established laboratory or clinical parameters.

Landberg E, Dahlström U, Alehagen U. Landberg E, et al. Among authors: alehagen u. Ann Clin Biochem. 2011 Jan;48(Pt 1):51-6. doi: 10.1258/acb.2010.010164. Epub 2010 Nov 29. Ann Clin Biochem. 2011. PMID: 21115571

52

Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. J Card Fail. 2013 Jan;19(1):31-9. doi: 10.1016/j.cardfail.2012.11.002. J Card Fail. 2013. PMID: 23273592

53

Sleep disordered breathing, hypoxia and inflammation: associations with sickness behaviour in community dwelling elderly with and without cardiovascular disease.

Johansson P, Svensson E, Alehagen U, Dahlström U, Jaarsma T, Broström A. Johansson P, et al. Among authors: alehagen u. Sleep Breath. 2015 Mar;19(1):263-71. doi: 10.1007/s11325-014-1006-9. Epub 2014 May 25. Sleep Breath. 2015. PMID: 24859483

54

Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised interventional component.

Charitakis E, Walfridsson U, Nyström F, Nylander E, Strömberg A, Alehagen U, Walfridsson H. Charitakis E, et al. Among authors: alehagen u. BMJ Open. 2015 Dec 21;5(12):e008723. doi: 10.1136/bmjopen-2015-008723. BMJ Open. 2015. PMID: 26692555 Free PMC article. Clinical Trial.

55

Responder to BNP-guided treatment in heart failure. The process of defining a responder.

Karlström P, Dahlström U, Boman K, Alehagen U. Karlström P, et al. Among authors: alehagen u. Scand Cardiovasc J. 2015;49(6):316-24. doi: 10.3109/14017431.2015.1070961. Epub 2015 Sep 23. Scand Cardiovasc J. 2015. PMID: 26153427 Clinical Trial.

56

Sleep disordered breathing, insomnia, and health related quality of life -- a comparison between age and gender matched elderly with heart failure or without cardiovascular disease.

Johansson P, Arestedt K, Alehagen U, Svanborg E, Dahlström U, Broström A. Johansson P, et al. Among authors: alehagen u. Eur J Cardiovasc Nurs. 2010 Jun;9(2):108-17. doi: 10.1016/j.ejcnurse.2009.11.005. Epub 2010 Jan 6. Eur J Cardiovasc Nurs. 2010. PMID: 20056491

57

An Internet-Based Cognitive Behavioral Therapy Program Adapted to Patients With Cardiovascular Disease and Depression: Randomized Controlled Trial.

Johansson P, Westas M, Andersson G, Alehagen U, Broström A, Jaarsma T, Mourad G, Lundgren J. Johansson P, et al. Among authors: alehagen u. JMIR Ment Health. 2019 Oct 3;6(10):e14648. doi: 10.2196/14648. JMIR Ment Health. 2019. PMID: 31584000 Free PMC article.

58

Are there any significant differences between females and males in the management of heart failure? Gender aspects of an elderly population with symptoms associated with heart failure.

Alehagen U, Ericsson A, Dahlström U. Alehagen U, et al. J Card Fail. 2009 Aug;15(6):501-7. doi: 10.1016/j.cardfail.2009.01.010. Epub 2009 Mar 17. J Card Fail. 2009. PMID: 19643361

59

The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study.

Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U. Karlström P, et al. Among authors: alehagen u. Int J Cardiol. 2017 Jun 1;236:315-320. doi: 10.1016/j.ijcard.2017.02.054. Epub 2017 Feb 17. Int J Cardiol. 2017. PMID: 28268084 Clinical Trial.

60

The contribution of hypoxia to the association between sleep apnoea, insomnia, and cardiovascular mortality in community-dwelling elderly with and without cardiovascular disease.

Johansson P, Svensson E, Alehagen U, Jaarsma T, Broström A. Johansson P, et al. Among authors: alehagen u. Eur J Cardiovasc Nurs. 2015 Jun;14(3):222-31. doi: 10.1177/1474515114524072. Epub 2014 Feb 7. Eur J Cardiovasc Nurs. 2015. PMID: 24509843

61

Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.

Charitakis E, Walfridsson H, Nylander E, Alehagen U. Charitakis E, et al. Among authors: alehagen u. J Am Heart Assoc. 2016 Dec 12;5(12):e003957. doi: 10.1161/JAHA.116.003957. J Am Heart Assoc. 2016. PMID: 27956398 Free PMC article. Clinical Trial.

62

Imaging Congestion With a Pocket Ultrasound Device: Prognostic Implications in Patients With Chronic Heart Failure.

Gustafsson M, Alehagen U, Johansson P. Gustafsson M, et al. Among authors: alehagen u. J Card Fail. 2015 Jul;21(7):548-54. doi: 10.1016/j.cardfail.2015.02.004. Epub 2015 Feb 25. J Card Fail. 2015. PMID: 25725475

63

Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.

Alehagen U, Goetze JP, Dahlström U. Alehagen U, et al. Clin Chim Acta. 2007 Jul;382(1-2):8-14. doi: 10.1016/j.cca.2007.03.005. Epub 2007 Mar 14. Clin Chim Acta. 2007. PMID: 17433809

64

Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects.

Rådholm K, Östgren CJ, Alehagen U, Falk M, Wressle E, Marcusson J, Nägga K. Rådholm K, et al. Among authors: alehagen u. Arch Gerontol Geriatr. 2011 May-Jun;52(3):e170-5. doi: 10.1016/j.archger.2010.10.024. Epub 2010 Nov 18. Arch Gerontol Geriatr. 2011. PMID: 21093071

65

Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.

Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T. Björck HM, et al. Among authors: alehagen u. Am J Hypertens. 2011 Jul;24(7):802-8. doi: 10.1038/ajh.2011.63. Epub 2011 Apr 14. Am J Hypertens. 2011. PMID: 21490692

66

Impaired abdominal aortic wall integrity in elderly men carrying the angiotensin-converting enzyme D allele.

Ljungberg LU, De Basso R, Alehagen U, Björck HM, Persson K, Dahlström U, Länne T. Ljungberg LU, et al. Among authors: alehagen u. Eur J Vasc Endovasc Surg. 2011 Sep;42(3):309-16. doi: 10.1016/j.ejvs.2011.04.010. Epub 2011 May 12. Eur J Vasc Endovasc Surg. 2011. PMID: 21570325 Free article.

67

The contribution of heart failure to sleep disturbances and depressive symptoms in older adults.

Johansson P, Riegel B, Svensson E, Broström A, Alehagen U, Dahlström U, Jaarsma T. Johansson P, et al. Among authors: alehagen u. J Geriatr Psychiatry Neurol. 2012 Sep;25(3):179-87. doi: 10.1177/0891988712458366. J Geriatr Psychiatry Neurol. 2012. PMID: 23124012

68

4D flow MRI can detect subtle right ventricular dysfunction in primary left ventricular disease.

Fredriksson AG, Svalbring E, Eriksson J, Dyverfeldt P, Alehagen U, Engvall J, Ebbers T, Carlhäll CJ. Fredriksson AG, et al. Among authors: alehagen u. J Magn Reson Imaging. 2016 Mar;43(3):558-65. doi: 10.1002/jmri.25015. Epub 2015 Jul 24. J Magn Reson Imaging. 2016. PMID: 26213253 Free article.

69

Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.

Charitakis E, Walfridsson H, Alehagen U. Charitakis E, et al. Among authors: alehagen u. J Am Heart Assoc. 2016 Sep 15;5(9):e003557. doi: 10.1161/JAHA.116.003557. J Am Heart Assoc. 2016. PMID: 27633393 Free PMC article.

70

Mechanical dyssynchrony alters left ventricular flow energetics in failing hearts with LBBB: a 4D flow CMR pilot study.

Zajac J, Eriksson J, Alehagen U, Ebbers T, Bolger AF, Carlhäll CJ. Zajac J, et al. Among authors: alehagen u. Int J Cardiovasc Imaging. 2018 Apr;34(4):587-596. doi: 10.1007/s10554-017-1261-5. Epub 2017 Nov 2. Int J Cardiovasc Imaging. 2018. PMID: 29098524 Free PMC article.

71

Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study.

Karlström P, Johansson P, Dahlström U, Boman K, Alehagen U. Karlström P, et al. Among authors: alehagen u. BMC Cardiovasc Disord. 2016 Feb 13;16:39. doi: 10.1186/s12872-016-0221-7. BMC Cardiovasc Disord. 2016. PMID: 26905220 Free PMC article. Clinical Trial.

72

Elevated circulating levels of thioredoxin and stress in chronic heart failure.

Jekell A, Hossain A, Alehagen U, Dahlström U, Rosén A. Jekell A, et al. Among authors: alehagen u. Eur J Heart Fail. 2004 Dec;6(7):883-90. doi: 10.1016/j.ejheart.2004.03.003. Eur J Heart Fail. 2004. PMID: 15556050 Free article.

73

Association of genetic variation on chromosome 9p21.3 and arterial stiffness.

Björck HM, Länne T, Alehagen U, Persson K, Rundkvist L, Hamsten A, Dahlström U, Eriksson P. Björck HM, et al. Among authors: alehagen u. J Intern Med. 2009 Mar;265(3):373-81. doi: 10.1111/j.1365-2796.2008.02020.x. Epub 2008 Oct 25. J Intern Med. 2009. PMID: 19019192 Free article.

74

Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. Clin Chem. 2010 Nov;56(11):1718-24. doi: 10.1373/clinchem.2009.141341. Epub 2010 Sep 15. Clin Chem. 2010. PMID: 20844063

75

Vitamin D levels and depressive symptoms in patients with chronic heart failure.

Johansson P, Alehagen U, van der Wal MH, Svensson E, Jaarsma T. Johansson P, et al. Among authors: alehagen u. Int J Cardiol. 2016 Mar 15;207:185-9. doi: 10.1016/j.ijcard.2016.01.173. Epub 2016 Jan 12. Int J Cardiol. 2016. PMID: 26803239

76

Sex-specific associations between self-reported sleep duration, depression, anxiety, fatigue and daytime sleepiness in an older community-dwelling population.

Broström A, Wahlin Å, Alehagen U, Ulander M, Johansson P. Broström A, et al. Among authors: alehagen u. Scand J Caring Sci. 2018 Mar;32(1):290-298. doi: 10.1111/scs.12461. Epub 2017 Jun 2. Scand J Caring Sci. 2018. PMID: 28574585

77

Higher blood pressure in elderly hypertensive females, with increased arterial stiffness and blood pressure in females with the Fibrillin-1 2/3 genotype.

Åström Malm I, Alehagen U, Blomstrand P, Dahlström U, De Basso R. Åström Malm I, et al. Among authors: alehagen u. BMC Cardiovasc Disord. 2020 Apr 17;20(1):180. doi: 10.1186/s12872-020-01454-9. BMC Cardiovasc Disord. 2020. PMID: 32303188 Free PMC article.

78

Clinical characteristics and mortality risk in relation to obstructive and central sleep apnoea in community-dwelling elderly individuals: a 7-year follow-up.

Johansson P, Alehagen U, Svanborg E, Dahlström U, Broström A. Johansson P, et al. Among authors: alehagen u. Age Ageing. 2012 Jul;41(4):468-74. doi: 10.1093/ageing/afs019. Epub 2012 Mar 22. Age Ageing. 2012. PMID: 22440587

79

The benefits of using a heart failure management programme in Swedish primary healthcare.

Agvall B, Alehagen U, Dahlström U. Agvall B, et al. Among authors: alehagen u. Eur J Heart Fail. 2013 Feb;15(2):228-36. doi: 10.1093/eurjhf/hfs159. Epub 2012 Oct 29. Eur J Heart Fail. 2013. PMID: 23109650 Free article. Clinical Trial.

80

Sleep disordered breathing in an elderly community-living population: Relationship to cardiac function, insomnia symptoms and daytime sleepiness.

Johansson P, Alehagen U, Svanborg E, Dahlström U, Broström A. Johansson P, et al. Among authors: alehagen u. Sleep Med. 2009 Oct;10(9):1005-11. doi: 10.1016/j.sleep.2009.01.011. Epub 2009 May 22. Sleep Med. 2009. PMID: 19464948

81

Determinants of global perceived health in community-dwelling elderly screened for heart failure and sleep-disordered breathing.

Johansson P, Alehagen U, Svensson E, Svanborg E, Dahlström U, Broström A. Johansson P, et al. Among authors: alehagen u. J Cardiovasc Nurs. 2010 Sep-Oct;25(5):E16-26. doi: 10.1097/JCN.0b013e3181d6de6f. J Cardiovasc Nurs. 2010. PMID: 20671565

82

Quality-adjusted life year weights among elderly patients with heart failure.

Alehagen U, Rahmqvist M, Paulsson T, Levin LA. Alehagen U, et al. Eur J Heart Fail. 2008 Oct;10(10):1033-9. doi: 10.1016/j.ejheart.2008.07.015. Epub 2008 Aug 28. Eur J Heart Fail. 2008. PMID: 18760669 Free article.

83

Resource use and cost implications of implementing a heart failure program for patients with systolic heart failure in Swedish primary health care.

Agvall B, Paulsson T, Foldevi M, Dahlström U, Alehagen U. Agvall B, et al. Among authors: alehagen u. Int J Cardiol. 2014 Oct 20;176(3):731-8. doi: 10.1016/j.ijcard.2014.07.105. Epub 2014 Aug 2. Int J Cardiol. 2014. PMID: 25131925 Clinical Trial.

84

Pocket-sized ultrasound examination of fluid imbalance in patients with heart failure: a pilot and feasibility study of heart failure nurses without prior experience of ultrasonography.

Gustafsson M, Alehagen U, Johansson P. Gustafsson M, et al. Among authors: alehagen u. Eur J Cardiovasc Nurs. 2015 Aug;14(4):294-302. doi: 10.1177/1474515114559435. Epub 2014 Nov 5. Eur J Cardiovasc Nurs. 2015. PMID: 25376773

85

Comparison of the Chronic Kidney Disease Epidemiology Collaboration, the Modification of Diet in Renal Disease study and the Cockcroft-Gault equation in patients with heart failure.

Szummer K, Evans M, Carrero JJ, Alehagen U, Dahlström U, Benson L, Lund LH. Szummer K, et al. Among authors: alehagen u. Open Heart. 2017 Jun 8;4(2):e000568. doi: 10.1136/openhrt-2016-000568. eCollection 2017. Open Heart. 2017. PMID: 28761677 Free PMC article.

86

Global perceived health and health-related quality of life in elderly primary care patients with symptoms of heart failure.

Johansson P, Broström A, Dahlström U, Alehagen U. Johansson P, et al. Among authors: alehagen u. Eur J Cardiovasc Nurs. 2008 Dec;7(4):269-76. doi: 10.1016/j.ejcnurse.2007.12.002. Epub 2008 Jan 14. Eur J Cardiovasc Nurs. 2008. PMID: 18249036

87

Making sense of chromogranin A in heart disease.

Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: alehagen u. Lancet Diabetes Endocrinol. 2013 Sep;1(1):7-8. doi: 10.1016/S2213-8587(13)70035-4. Epub 2013 Jun 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622255 Review. No abstract available.

88

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome.

Karlström P, Alehagen U, Boman K, Dahlström U; UPSTEP-study group. Karlström P, et al. Among authors: alehagen u. Eur J Heart Fail. 2011 Oct;13(10):1096-103. doi: 10.1093/eurjhf/hfr078. Epub 2011 Jun 29. Eur J Heart Fail. 2011. PMID: 21715446 Free article. Clinical Trial.

89

Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure.

Linde C, Ståhlberg M, Benson L, Braunschweig F, Edner M, Dahlström U, Alehagen U, Lund LH. Linde C, et al. Among authors: alehagen u. Europace. 2015 Mar;17(3):424-31. doi: 10.1093/europace/euu205. Epub 2014 Aug 27. Europace. 2015. PMID: 25164429

90

Left ventricular hemodynamic forces as a marker of mechanical dyssynchrony in heart failure patients with left bundle branch block.

Eriksson J, Zajac J, Alehagen U, Bolger AF, Ebbers T, Carlhäll CJ. Eriksson J, et al. Among authors: alehagen u. Sci Rep. 2017 Jun 7;7(1):2971. doi: 10.1038/s41598-017-03089-x. Sci Rep. 2017. PMID: 28592851 Free PMC article.

91

N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification.

Hunter I, Alehagen U, Dahlström U, Rehfeld JF, Crimmins DL, Goetze JP. Hunter I, et al. Among authors: alehagen u. Clin Chem. 2011 Sep;57(9):1327-30. doi: 10.1373/clinchem.2011.166330. Epub 2011 Jun 29. Clin Chem. 2011. PMID: 21715695

92

Atlas-based analysis of 4D flow CMR: automated vessel segmentation and flow quantification.

Bustamante M, Petersson S, Eriksson J, Alehagen U, Dyverfeldt P, Carlhäll CJ, Ebbers T. Bustamante M, et al. Among authors: alehagen u. J Cardiovasc Magn Reson. 2015 Oct 5;17:87. doi: 10.1186/s12968-015-0190-5. J Cardiovasc Magn Reson. 2015. PMID: 26438074 Free PMC article.

93

A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting.

Alehagen U, Janzon M. Alehagen U, et al. Eur J Heart Fail. 2008 Mar;10(3):260-6. doi: 10.1016/j.ejheart.2008.01.005. Epub 2008 Mar 4. Eur J Heart Fail. 2008. PMID: 18304871 Free article.

94

Selenium and Coenzyme Q₁₀ Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial.

Opstad TB, Alexander J, Aaseth JO, Larsson A, Seljeflot I, Alehagen U. Opstad TB, et al. Among authors: alehagen u. Nutrients. 2022 Aug 15;14(16):3346. doi: 10.3390/nu14163346. Nutrients. 2022. PMID: 36014852 Free PMC article. Clinical Trial.

95

Improved cardiovascular health by supplementation with selenium and coenzyme Q10: applying structural equation modelling (SEM) to clinical outcomes and biomarkers to explore underlying mechanisms in a prospective randomized double-blind placebo-controlled intervention project in Sweden.

Alehagen U, Johansson P, Svensson E, Aaseth J, Alexander J. Alehagen U, et al. Eur J Nutr. 2022 Sep;61(6):3135-3148. doi: 10.1007/s00394-022-02876-1. Epub 2022 Apr 6. Eur J Nutr. 2022. PMID: 35381849 Free PMC article. Clinical Trial.

96

Decreased Concentration of Fibroblast Growth Factor 23 (FGF-23) as a Result of Supplementation with Selenium and Coenzyme Q₁₀ in an Elderly Swedish Population: A Sub-Analysis.

Alehagen U, Aaseth J, Larsson A, Alexander J. Alehagen U, et al. Cells. 2022 Feb 1;11(3):509. doi: 10.3390/cells11030509. Cells. 2022. PMID: 35159318 Free PMC article. Clinical Trial.

97

Endocrine and Mechanical Cardiacfunction Four Months after Radiofrequency Ablation of Atrialfibrillation.

Charitakis E, OKarlsson L, Carlhäll CJ, Liuba I, Jönsson AH, Walfridsson H, Alehagen U. Charitakis E, et al. Among authors: alehagen u. J Atr Fibrillation. 2021 Jun 30;14(1):20200454. doi: 10.4022/jafib.20200454. eCollection 2021 Jun-Jul. J Atr Fibrillation. 2021. PMID: 34950357 Free PMC article.

98

Impact of Selenium on Biomarkers and Clinical Aspects Related to Ageing. A Review.

Alehagen U, Opstad TB, Alexander J, Larsson A, Aaseth J. Alehagen U, et al. Biomolecules. 2021 Oct 7;11(10):1478. doi: 10.3390/biom11101478. Biomolecules. 2021. PMID: 34680111 Free PMC article. Review.

99

The Aging Kidney-As Influenced by Heavy Metal Exposure and Selenium Supplementation.

Aaseth J, Alexander J, Alehagen U, Tinkov A, Skalny A, Larsson A, Crisponi G, Nurchi VM. Aaseth J, et al. Among authors: alehagen u. Biomolecules. 2021 Jul 22;11(8):1078. doi: 10.3390/biom11081078. Biomolecules. 2021. PMID: 34439746 Free PMC article. Review.

100

Coenzyme Q₁₀ supplementation - In ageing and disease.

Aaseth J, Alexander J, Alehagen U. Aaseth J, et al. Among authors: alehagen u. Mech Ageing Dev. 2021 Jul;197:111521. doi: 10.1016/j.mad.2021.111521. Epub 2021 Jun 12. Mech Ageing Dev. 2021. PMID: 34129891 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results